JOURNAL OF CLINICAL SURGERY ›› 2019, Vol. 27 ›› Issue (5): 446-448.doi: 10.3969/j.issn.1005-6483.2019.05.028
Previous Articles Next Articles
Online:
Published:
Abstract: Nowadays,the incidence of esophagogastric junction tumor is increasing year by year,and the prognosis of the patients is poor.Surgery is still the most feasible treatment,but surgery alone is not effective.Preoperative chemoradiotherapy is the standard treatment regimen for patients with esophagogastric junction tumor in western countries,while eastern countries prefer perioperative chemotherapy regimen.The emergence of targeted therapy will bring new hope to patients with esophagogastric junction tumor.We will discuss the treatment of the esophagogastric junction tumor,combining with multiple clinical trials and the latest research.
Key words: esophagogastric junction tumor, surgery, chemoradiotherapy, targeted therapy
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.lcwkzz.com/EN/10.3969/j.issn.1005-6483.2019.05.028
http://www.lcwkzz.com/EN/Y2019/V27/I5/446
Cited